As the World Health Organization intensifies its campaign against nicotine pouches, vaping products and other smoke-free alternatives, a glaring reality challenges the global public health narrative with a simple question: if these products are the problem, why is Sweden achieving some of the best smoking-related health outcomes in the world? The contrast could not be any sharper.
While many Western countries battle persistent smoking rates, Sweden has become the first European nation to reach a smoke-free status, with smoking prevalence having fallen to less than 5 per cent. More importantly, Sweden records some of Europe’s lowest rates of lung cancer, tobacco-related mortality and smoking-associated diseases. The key difference is not nicotine abstinence. It is the widespread replacement of cigarettes with significantly lower-risk alternatives such as snus and nicotine pouches.
Why Sweden is a thorn in the WHO’s side
Sweden’s experience demonstrates what happens when public policy focuses on reducing exposure to smoke rather than attempting to eliminate nicotine use altogether. And this reality is deeply inconvenient to major groups who keep pushing for nicotine prohibition, such as the WHO and the EU.
This distinction remains at the centre of the tobacco harm reduction (THR) debate. Decades of scientific evidence show that the overwhelming health risks from smoking come from combustion. When tobacco burns, it produces thousands of chemicals, including dozens of known carcinogens and toxic gases. Nicotine is addictive, but it is not the primary cause of smoking-related cancers, cardiovascular disease or chronic respiratory illness. Sweden’s experience demonstrates what happens when public policy focuses on reducing exposure to smoke rather than attempting to eliminate nicotine use altogether. And this reality is deeply inconvenient to major groups who keep pushing for nicotine prohibition, such as the WHO and the EU.In fact, despite Sweden’s positive results, the WHO continues to shed a very negative light on safer alternatives such as nicotine pouches. Its latest report portrays the products as a youth-focused threat, calling for stricter regulations, flavour restrictions and taxation measures. THR experts highlight that this approach largely ignores the products’ role in helping adult smokers move away from combustible tobacco. They argue that focusing too much on nicotine risks obscures this larger objective.
Among these experts is public health consultant Clive Bates, who points out that tobacco policy should be judged primarily on whether it accelerates the transition away from smoking. The relevant comparison is not between nicotine pouches and abstinence, but between nicotine pouches and continued cigarette smoking. In line with this, the WHO has faced a community-led fact-check after Director-General Tedros Adhanom Ghebreyesus promoted a World No Tobacco Day video urging governments to ban flavoured vapes, restrict advertising and tighten product regulations.
WHO contradicts its own data
In the post, Tedros stated that at least 40 million children aged 13–15 use tobacco products and that 15 million use e-cigarettes, arguing that nicotine companies continue to drive youth addiction. Critics responded by adding contextual information to the post, highlighting that the WHO’s own data shows youth vaping represents a relatively small proportion of overall nicotine use and that the organisation’s focus on vaping overlooks its potential role in reducing smoking-related harm among adults.
There has also been a lot of talk about this risk-proportionate approach when it comes to nicotine products. New studies are showing that non-combustible options, like nicotine pouches and vaping, expose users to way fewer harmful substances compared to traditional cigarettes. Independent researchers and health groups have confirmed that vapes, nicotine pouches and snus are the safest non-pharmaceutical choices in the nicotine world. Importantly, they are the most effective.
The WHO, however, continues to prioritise concerns about youth uptake. Protecting minors is essential, and of course, harm reduction advocates support the need for strict age-verification systems, marketing restrictions and enforcement measures. Yet, any restrictions must not make lower-risk alternatives less accessible to adult smokers.
The science on what works is undeniable
Ultimately, the fact that prohibition-oriented approaches create unintended consequences is undeniable. Studies have consistently shown that when legal options are scarce, people don’t just give up on wanting those products. They often resort to underground or illegal sources, which are potentially unsafe and feed criminal networks. Australia remains a prime (tragic) example of this.
Nicotine products should definitely not be marketed to minors or non-nicotine users; no one is disputing that. But this can be prevented while still acknowledging the major differences in risk between cigarettes and smoke-free alternatives. The fundamental question facing policymakers remains straightforward: should public health strategies prioritise ideal outcomes or achievable ones?
https://www.vapingpost.com/2026/05/19/who-nicotine-pouch-report-sparks-backlash-as-experts-highlight-safer-alternatives-are-being-ignored/
